07:00 , Sep 3, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Myotubularin related protein 3 (MTMR3)

Autoimmune disease INDICATION: Inflammatory bowel disease (IBD) In vitro studies suggest inhibiting MTMR3 could help treat IBD in patients who harbor the rs713875 risk variant. In primary human monocyte-derived macrophages, a bacterial peptidoglycan recognized by pattern recognition...